Novartis Technical Operations (NTO) is the manufacturing division of Novartis. We strive to deliver high quality, affordable medicines on time, every time, safely and efficiently, and become the top manufacturer of innovative and generic medicines in the industry - while keeping our patients at the heart of everything we do.
How do we aim to do it?
We in NTO play a critical role in enabling the company’s mission to reimagine medicine by providing the manufacturing technology that enables breakthrough medical innovation to deliver our medicines to patients. As Novartis continues to evolve, we are fundamentally transforming the way we work to match our capacity and capabilities to the changing demands of the product portfolio. Building on our strengths, we are re-imagining manufacturing and supply to continue to serve our patients and the business sustainably now and in the years to come.
As one of the largest divisions within Novartis, we take necessary actions to overcome headwinds via standardization, creating more value through our supplier relationships, network transformation / synergies and data & technology. We have committed to ambitious goals for the future of our operations that will help Novartis continue to reimagine manufacturing by making high quality medicines accessible to patients around the world.
5 integrated Manufacturing and Supply units with end-to-end responsibility for manufacturing, internal & external supply.
Large Molecules Platform
The creation of the Large Molecules Platform represents the next step in the evolution of NTO’s platform structure, based on synergies and interlinks between the Biotech Drug Substance sites (comprising management of cell banks, upstream and downstream processes) and Drug Product sites (that include formulation, filling under aseptic conditions and packaging).
Small Molecules Platform
This platform aims to optimize and further enhance the end-to-end supply of small molecules innovative medicines products to become a top class customer service center and reliable partner to our customers and patients.
Sandoz Technical Operations Platform
The platform has full end-to-end responsibility for all dedicated Sandoz production sites, Sandoz external suppliers and the end-to-end Sandoz Supply Chain. TechOps Strategy, network decisions, Capex allocation, supply point decisions and volume strategy (including CMO/B2B) are fully owned by this team and are developed and executed in full alignment with the Sandoz Divisional Strategy.
Cell & Gene Therapy Platform
The Cell and Gene Therapy Platform mission is to deliver timely access to cost-effective, quality, innovative medicines which improve and extend patient lives.
Local Market Manufacturing
The platform is focused on manufacturing and supplying affordable medicines locally to patients and customers in their respective countries.
In Quality, our guiding purpose is to have a positive impact on patients. With a goal to go beyond compliance and look to serve our patients effectively, we are transforming to become an agile quality organization by –
simplifying our operations for efficiency
eliminating duplication and
innovating how we work
to focus on what really matters, making and supplying life-changing medicines to our patients.
3 years, 4 sites, 3 production platforms. Having started as a trainee, I have since moved into a position which is central to our production organization where I am able to improve and stabilize processes by working closely with colleagues across different functions.
Why apply your skills and knowledge at Novartis?
We recognize career development stems from personal growth, and personal growth stems from experiences. We are ‘unbossed’ to drive our own personal growth, to feed our curiosity, and to challenge, stretch and enhance our skills and knowledge.